Pharmaceuticals
Nestle to buy Canadian vitamin maker Atrium for $2.3 bn
07 Dec 2017
Swiss food and drink giant Nestle SA yesterday struck a deal to buy Canadian privately-held vitamin maker Atrium Innovations for $2.3 billion in order to expand its consumer healthcare portfolio
WHO to review Sanofi’s dengue vaccine Dengvaxia over safety concerns
05 Dec 2017
The review comes after the French pharma giant’s own admission that its dengue vaccine could have unintended consequences in patients who had never been infected with the mosquito-borne virus and the Philippines halted its use
Nestle, Bain Capital, Cinven in race for Merck KgaA’s consumer health unit
02 Dec 2017
Swiss food giant Nestle and private equity firms Bain Capital and Cinven – owners of German drug firm Stada — are in the race to buy Merck KgaA’s consumer health unit
.webp)
.webp)
